Stock Comparison

MDLN vs RMD

Medline Inc. Class A Common Stock and ResMed Inc side by side — valuation, profitability, growth and risk.

MDLN

Medline Inc. Class A Common Stock

Valuation

Market Cap

$69.26B

$29.05B

P/E (TTM)

34.1

19.3

Forward P/E

26.3

16.9

Price/Sales

2.4

5.3

Price/Book

2.9

4.5

EV/EBITDA

14.6

13.0

Dividend Yield

—

1.17%

Profitability

Net Margin

3.32%

27.40%

Operating Margin

5.43%

35.30%

Return on Equity

6.05%

25.30%

Return on Assets

3.66%

14.70%

Growth (YoY)

Revenue Growth

10.70%

10.80%

Earnings Growth

1258.00%

10.50%

Price & Risk

Beta

—

0.8

52-Week High

$50.88

$291.57

52-Week Low

$32.81

$180.27

Analyst Target

$51.15

$260.60

Compare MDLN and RMD your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.